MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/aogs.14985

Медицинская библиотека · Acta obstetricia et gynecologica Scandinavica · 2024

Optimizing care for MRKH patients: From malformation screening to uterus transplantation eligibility.

Cospain Auriane, Dion Ludivine, Bidet Maud, Nyangoh Timoh Krystel, Quelin Chloé, Carton Isis, Lavillaureix Alinoe, Morcel Karine, Rollier Paul, Pasquier Laurent, Nouyou Bénédicte, Odent Sylvie, Guerrier Daniel, Launay Erika, Belaud Rotureau Marc-Antoine, Fradin Mélanie, Jaillard Sylvie, Lavoué Vincent

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with utero-vaginal aplasia is the most severe form of the Müllerian duct anomalies and can be associated with extra-genital abnormalities such as renal or skeletal anomalies, hearing loss, or cardiac defects. The past two decades have witnessed significant advances both in understanding the etiologies of MRKH and in the development of fertility treatments such as uterine transplantation. The present work aimed to determine the rate of women with MRKH syndrome who underwent optimal initial management (after comprehensive malformation assessment) and to establish the rate of patients eligible for uterine transplantation (i.e., those with a vaginal length ≥7 cm without reconstruction using a bowel segment, and an anti-Müllerian hormone level >1.5 ng/mL before 35 years).

MATERIAL AND

METHODS

Cohort study of 85 women with MRKH syndrome consulting in our tertiary center.

RESULTS

62.4% of women with MRKH syndrome had an exhaustive malformative evaluation according to the French guidelines (Protocole National de Diagnostic et de Soin [PNDS]), of which 76.5% had associated malformations (MRKH type II). Pedigree, when available, showed a family history of infertility or a urogenital tract spectrum anomaly in 60% of cases. Concerning the uterine transplantation selection criteria, when evaluated, 22.6% of women had an anti-Müllerian hormone level <1.5 ng/mL and 36% a vaginal length <7 cm. On the 21 women with complete evaluation of both primary and secondary outcomes, 14 of them would be eligible for a uterine transplantation program at the time of consultation according to the main inclusion criteria of uterine transplantation program.

CONCLUSIONS

Women with MRKH syndrome are often inadequately explored for associated malformations. Early assessment and monitoring of the ovarian reserve is key for fertility preservation, especially in the era of uterine transplantation.

Для цитирования: Cospain Auriane, Dion Ludivine, Bidet Maud, Nyangoh Timoh Krystel, Quelin Chloé, Carton Isis, Lavillaureix Alinoe, Morcel Karine, Rollier Paul, Pasquier Laurent, Nouyou Bénédicte, Odent Sylvie, Guerrier Daniel, Launay Erika, Belaud Rotureau Marc-Antoine, Fradin Mélanie, Jaillard Sylvie, Lavoué Vincent. Optimizing care for MRKH patients: From malformation screening to uterus transplantation eligibility.. Acta obstetricia et gynecologica Scandinavica. 2024. DOI: 10.1111/aogs.14985.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.